DK2468094T3 - Sammensætning og fremgangsmåder til modulation af vaskulær struktur og/eller funktion - Google Patents

Sammensætning og fremgangsmåder til modulation af vaskulær struktur og/eller funktion

Info

Publication number
DK2468094T3
DK2468094T3 DK11192813T DK11192813T DK2468094T3 DK 2468094 T3 DK2468094 T3 DK 2468094T3 DK 11192813 T DK11192813 T DK 11192813T DK 11192813 T DK11192813 T DK 11192813T DK 2468094 T3 DK2468094 T3 DK 2468094T3
Authority
DK
Denmark
Prior art keywords
procedures
composition
function
vascular structure
modulating vascular
Prior art date
Application number
DK11192813T
Other languages
Danish (da)
English (en)
Inventor
John N Vournakis
Sergio Finkielsztein
Original Assignee
Marinepolymer Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marinepolymer Tech Inc filed Critical Marinepolymer Tech Inc
Application granted granted Critical
Publication of DK2468094T3 publication Critical patent/DK2468094T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
DK11192813T 2001-02-12 2002-02-08 Sammensætning og fremgangsmåder til modulation af vaskulær struktur og/eller funktion DK2468094T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/781,182 US7041657B2 (en) 2001-02-12 2001-02-12 Compositions and methods for modulation of vascular structure and/or function
EP20020740104 EP1365651B1 (en) 2001-02-12 2002-02-08 Composition and methods for modulation of vascular structure and/or function

Publications (1)

Publication Number Publication Date
DK2468094T3 true DK2468094T3 (da) 2014-07-21

Family

ID=25121948

Family Applications (2)

Application Number Title Priority Date Filing Date
DK11192813T DK2468094T3 (da) 2001-02-12 2002-02-08 Sammensætning og fremgangsmåder til modulation af vaskulær struktur og/eller funktion
DK02740104T DK1365651T3 (da) 2001-02-12 2002-02-08 Sammensætning og fremgangsmåder til modulation af vaskulær struktur og/eller funktion

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK02740104T DK1365651T3 (da) 2001-02-12 2002-02-08 Sammensætning og fremgangsmåder til modulation af vaskulær struktur og/eller funktion

Country Status (12)

Country Link
US (7) US7041657B2 (US20030078234A1-20030424-C00005.png)
EP (2) EP2468094B1 (US20030078234A1-20030424-C00005.png)
JP (4) JP5303088B2 (US20030078234A1-20030424-C00005.png)
AU (3) AU2002306455B2 (US20030078234A1-20030424-C00005.png)
CA (1) CA2437812C (US20030078234A1-20030424-C00005.png)
DK (2) DK2468094T3 (US20030078234A1-20030424-C00005.png)
ES (2) ES2477316T3 (US20030078234A1-20030424-C00005.png)
HK (1) HK1172504A1 (US20030078234A1-20030424-C00005.png)
IL (2) IL157327A0 (US20030078234A1-20030424-C00005.png)
MX (1) MXPA03007176A (US20030078234A1-20030424-C00005.png)
NZ (1) NZ527872A (US20030078234A1-20030424-C00005.png)
WO (1) WO2002063961A1 (US20030078234A1-20030424-C00005.png)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743783B1 (en) * 1993-12-01 2004-06-01 Marine Polymer Technologies, Inc. Pharmaceutical compositions comprising poly-β-1→4-N-acetylglucosamine
US5858350A (en) 1993-12-01 1999-01-12 Marine Polymer Technologies Methods and compositions for poly-β-1→4-N-acetylglucosamine cell therapy system
US7041657B2 (en) * 2001-02-12 2006-05-09 Marine Polymer Technologies Inc. Compositions and methods for modulation of vascular structure and/or function
JP2006515309A (ja) 2002-12-31 2006-05-25 マリン ポリマー テクノロジーズ，インコーポレーテッド 止血剤組成物およびその使用
WO2004076637A2 (en) 2003-02-24 2004-09-10 Marine Polymer Technologies, Inc. Cell-polymer fiber compositions and use thereof
US8613772B2 (en) * 2003-04-21 2013-12-24 Rsb Spine Llc Lateral mount implant device
AU2004273867B2 (en) * 2003-09-12 2011-01-27 Marine Polymer Technologies, Inc. Vascular access preservation in hemodialysis patients
US7803182B2 (en) * 2004-05-28 2010-09-28 Cordis Corporation Biodegradable vascular device with buffering agent
US7785615B2 (en) * 2004-05-28 2010-08-31 Cordis Corporation Biodegradable medical implant with encapsulated buffering agent
US20070031468A1 (en) * 2005-08-04 2007-02-08 Endomedix, Inc. Modified chitosan for vascular embolization
US20070031467A1 (en) * 2005-08-04 2007-02-08 Abrahams John M Composition and method for vascular embolization
US7854923B2 (en) * 2006-04-18 2010-12-21 Endomedix, Inc. Biopolymer system for tissue sealing
US20080075657A1 (en) * 2006-04-18 2008-03-27 Abrahams John M Biopolymer system for tissue sealing
US20070243130A1 (en) * 2006-04-18 2007-10-18 Weiliam Chen Biopolymer system for tissue sealing
US20090010982A1 (en) * 2006-04-18 2009-01-08 Endomedix, Inc. Biocompatible adherent sheet for tissue sealing
ES2918452T3 (es) 2007-02-19 2022-07-15 Marine Polymer Tech Inc Composiciones hemostáticas y regímenes terapéuticos
US8932560B2 (en) 2007-09-04 2015-01-13 University of Maryland, College Parke Advanced functional biocompatible polymeric matrix used as a hemostatic agent and system for damaged tissues and cells
NZ599338A (en) 2007-06-27 2013-11-29 Marinepolymer Tech Inc Complexes of il-15 and il-15ralpha and uses thereof
US8486033B2 (en) 2007-07-18 2013-07-16 Marine Polymer Technologies, Inc. Application of polymeric materials to screens to facilitate hemostasis and wound healing
US20130096518A1 (en) 2007-12-06 2013-04-18 Smith & Nephew Plc Wound filling apparatuses and methods
US11253399B2 (en) 2007-12-06 2022-02-22 Smith & Nephew Plc Wound filling apparatuses and methods
US9566256B2 (en) 2008-09-22 2017-02-14 Biochemics, Inc. Transdermal drug delivery using an osmolyte and vasoactive agent
EP2352543B1 (en) 2008-12-04 2019-04-03 BioChemics, Inc. Methods and compositions for tattoo removal
CA2780898A1 (en) 2009-11-13 2011-05-19 University Of Maryland, College Park Advanced functional biocompatible foam used as a hemostatic agent for compressible and non-compressible acute wounds
US8858964B2 (en) 2010-04-15 2014-10-14 Marine Polymer Technologies, Inc. Anti-bacterial applications of poly-N-acetylglucosamine nanofibers
CA2832859C (en) 2011-04-15 2020-06-16 Marine Polymer Technologies, Inc. Treatment of disease with poly-n-acetylglucosamine nanofibers
WO2014160136A1 (en) 2013-03-13 2014-10-02 University Of Maryland, Office Of Technology Commercialization Advanced functional biocompatible polymer putty used as a hemostatic agent for treating damaged tissue and cells
NZ729181A (en) 2013-03-14 2018-11-30 Marine Polymer Tech Inc Treatment of disease with poly-n-acetylglucosamine nanofibers
US10517988B1 (en) 2018-11-19 2019-12-31 Endomedix, Inc. Methods and compositions for achieving hemostasis and stable blood clot formation

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US585559A (en) * 1897-06-29 Piano-hammer
US3232836A (en) * 1959-08-24 1966-02-01 Pfizer & Co C Facilitating healing of body surface wounds by intravenous administration of n-acetyl glucosamine, glucosamine, or pharmaceutically acceptable acid salts of glucosamine
US3903268A (en) * 1968-02-12 1975-09-02 Lescarden Ltd Chitin and chitin derivatives for promoting wound healing
US3632754A (en) * 1968-02-12 1972-01-04 Lescarden Ltd Use of chitin for promoting wound healing
US3911116A (en) * 1970-04-13 1975-10-07 Leslie L Balassa Process for promoting wound healing with chitin derivatives
US3989535A (en) * 1974-02-11 1976-11-02 American Cyanamid Company Solution of poly(N-acetyl-D-glucosamine)
US4394373A (en) * 1981-04-06 1983-07-19 Malette William Graham Method of achieving hemostasis
JPS61240963A (ja) * 1985-04-18 1986-10-27 ユニチカ株式会社 創傷被覆保護材
JPH0813746B2 (ja) * 1987-02-27 1996-02-14 ユニチカ株式会社 止血剤
AU4834990A (en) 1988-12-07 1990-06-26 Bentech Laboratories, Inc. Formulations for treating slow and non-healing wounds
US5583107A (en) * 1990-09-04 1996-12-10 Cor Therapeutics, Inc. Agents affecting thrombosis and hemostasis
US6197325B1 (en) * 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
CA2059380A1 (en) * 1991-01-24 1992-07-25 Yiu-Kuen T. Lam Endothelin receptor antagonists isolated from microbispora
US5219749A (en) 1991-10-09 1993-06-15 Institute For Molecular Biology & Biotechnology/Forth Process for isolating and preparing purified chitin deacetylase
US5443481A (en) 1992-07-27 1995-08-22 Lee; Benjamin I. Methods and device for percutaneous sealing of arterial puncture sites
GB9305464D0 (en) * 1993-03-17 1993-05-05 Logax Limited Document file
JPH09504719A (ja) * 1993-11-03 1997-05-13 クラリオン、ファーマシューティカルズ、インコーポレイテッド 止血パッチ
US5437292A (en) * 1993-11-19 1995-08-01 Bioseal, Llc Method for sealing blood vessel puncture sites
US5686115A (en) 1993-12-01 1997-11-11 Marine Polymer Technologies, Inc. Poly-β-1→4-N-acetylucosamine copolymer composition with collagen
US5624679A (en) 1993-12-01 1997-04-29 Marine Polymer Technologies, Inc. Methods and compositions for poly-β-1-4-N-acetylglucosamine biological barriers
US5635493A (en) * 1993-12-01 1997-06-03 Marine Polymer Technologies, Inc. Methods and compositions for poly-β-1-4-N-acetylglucosamine chemotherapeutics
US5846952A (en) 1993-12-01 1998-12-08 Marine Polymer Technologies, Inc. Methods and compositions for poly-β-1-4-N-acetylglucosamine drug delivery
US5858350A (en) * 1993-12-01 1999-01-12 Marine Polymer Technologies Methods and compositions for poly-β-1→4-N-acetylglucosamine cell therapy system
US6063911A (en) 1993-12-01 2000-05-16 Marine Polymer Technologies, Inc. Methods and compositions for treatment of cell proliferative disorders
US5622834A (en) 1993-12-01 1997-04-22 Marine Polymer Technologies, Inc. Method of isolating poly-β-1-4-N-acetylglucosamine from microalgal culture
US6743783B1 (en) * 1993-12-01 2004-06-01 Marine Polymer Technologies, Inc. Pharmaceutical compositions comprising poly-β-1→4-N-acetylglucosamine
EP0748215B1 (en) * 1994-02-17 2003-05-28 New York Blood Center, Inc. Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use
WO1995032671A1 (en) * 1994-06-01 1995-12-07 Perclose, Inc. Method and device for providing vascular hemostasis
JPH0853368A (ja) * 1994-08-09 1996-02-27 Kyoto Yakuhin Kogyo Kk 軟膏製剤
US5814066A (en) * 1994-12-23 1998-09-29 The University Of Virginia Patent Foundation Reduction of femoral arterial bleeding post catheterization using percutaneous application of fibrin sealant
US5510102A (en) * 1995-01-23 1996-04-23 The Regents Of The University Of California Plasma and polymer containing surgical hemostatic adhesives
EP0754053A1 (en) * 1995-02-03 1997-01-22 Korea Institute of Science and Technology Novel hemostatic composition
AU5917896A (en) 1995-06-06 1996-12-24 Marine Polymer Technologies, Inc. Poly-beta-1-4-N-acetylglucosamine
JPH09169653A (ja) * 1995-12-22 1997-06-30 Unitika Ltd キチン止血剤
JPH09169654A (ja) * 1995-12-22 1997-06-30 Unitika Ltd 止血剤
US5728132A (en) * 1996-04-08 1998-03-17 Tricardia, L.L.C. Self-sealing vascular access device
JPH09291036A (ja) * 1996-04-26 1997-11-11 San Five Kk 粉末状キチン質創傷治療剤
JPH09328432A (ja) * 1996-06-06 1997-12-22 Unitika Ltd スプレー剤
JPH1075998A (ja) * 1996-09-05 1998-03-24 Unitika Ltd 綿状創傷保護材
US5855559A (en) * 1997-02-14 1999-01-05 Tricardia, Inc. Hemostatic agent delivery device having built-in pressure sensor
US6193670B1 (en) * 1997-02-14 2001-02-27 Tricardia, Llc Hemostatic agent delivery device having built-in pressure sensor
JPH10295699A (ja) * 1997-04-24 1998-11-10 Clinical Supply:Kk 止血用具
US6033427A (en) * 1998-01-07 2000-03-07 Lee; Benjamin I. Method and device for percutaneous sealing of internal puncture sites
US6056970A (en) * 1998-05-07 2000-05-02 Genzyme Corporation Compositions comprising hemostatic compounds and bioabsorbable polymers
US6613070B2 (en) * 1998-08-04 2003-09-02 Baxter International Inc. System and method for sealing vascular penetrations with hemostatic gels
US6334865B1 (en) * 1998-08-04 2002-01-01 Fusion Medical Technologies, Inc. Percutaneous tissue track closure assembly and method
US20020197302A1 (en) * 1998-11-12 2002-12-26 Cochrum Kent C. Hemostatic polymer useful for rapid blood coagulation and hemostasis
US6361551B1 (en) * 1998-12-11 2002-03-26 C. R. Bard, Inc. Collagen hemostatic fibers
JP4159682B2 (ja) * 1998-12-22 2008-10-01 株式会社クラレ 止血材
US7041657B2 (en) 2001-02-12 2006-05-09 Marine Polymer Technologies Inc. Compositions and methods for modulation of vascular structure and/or function
US6693188B2 (en) * 2001-08-08 2004-02-17 Cargill Incorporated N-acetyl-D-glucosamine and process for producing N-acetyl-D-glucosamine
US7371403B2 (en) * 2002-06-14 2008-05-13 Providence Health System-Oregon Wound dressing and method for controlling severe, life-threatening bleeding
JP2006515309A (ja) * 2002-12-31 2006-05-25 マリン ポリマー テクノロジーズ，インコーポレーテッド 止血剤組成物およびその使用
WO2004076637A2 (en) 2003-02-24 2004-09-10 Marine Polymer Technologies, Inc. Cell-polymer fiber compositions and use thereof
AU2004273867B2 (en) 2003-09-12 2011-01-27 Marine Polymer Technologies, Inc. Vascular access preservation in hemodialysis patients
ES2918452T3 (es) 2007-02-19 2022-07-15 Marine Polymer Tech Inc Composiciones hemostáticas y regímenes terapéuticos

Also Published As

Publication number Publication date
HK1172504A1 (en) 2013-04-26
US8859528B2 (en) 2014-10-14
US20100323986A1 (en) 2010-12-23
AU2007251899B2 (en) 2011-01-27
JP2014148517A (ja) 2014-08-21
NZ527872A (en) 2005-07-29
US20020019367A1 (en) 2002-02-14
JP5543861B2 (ja) 2014-07-09
AU2002306455B2 (en) 2007-12-13
US20130288999A1 (en) 2013-10-31
US7115588B2 (en) 2006-10-03
MXPA03007176A (es) 2005-02-14
US20030078234A1 (en) 2003-04-24
JP5945293B2 (ja) 2016-07-05
JP2004526705A (ja) 2004-09-02
AU2011200400A1 (en) 2011-02-24
EP2468094A1 (en) 2012-06-27
CA2437812C (en) 2012-08-28
US7041657B2 (en) 2006-05-09
US20090318383A1 (en) 2009-12-24
WO2002063961A1 (en) 2002-08-22
US20150118281A1 (en) 2015-04-30
ES2477316T3 (es) 2014-07-16
JP5303088B2 (ja) 2013-10-02
ES2456695T3 (es) 2014-04-23
WO2002063961B1 (en) 2003-03-06
EP1365651A4 (en) 2009-02-25
AU2011200400B2 (en) 2013-07-04
EP1365651A1 (en) 2003-12-03
JP2010265285A (ja) 2010-11-25
CA2437812A1 (en) 2002-08-22
US8481512B2 (en) 2013-07-09
IL157327A0 (en) 2004-02-19
DK1365651T3 (da) 2014-03-31
EP1365651B1 (en) 2014-01-08
AU2007251899A1 (en) 2008-01-24
US20070072826A1 (en) 2007-03-29
EP2468094B1 (en) 2014-04-16
IL157327A (en) 2010-12-30
JP2016053067A (ja) 2016-04-14

Similar Documents

Publication Publication Date Title
DK2468094T3 (da) Sammensætning og fremgangsmåder til modulation af vaskulær struktur og/eller funktion
DK1404873T3 (da) Kimæriske immunmodulatoriske forbindelser og fremgangsmåder til anvendelse deraf
DK1123313T3 (da) Fremgangsmåder og sammensætninger til forebyggelse og behandling af anæmi
DK1372501T3 (da) Occipitalplade og system til stabilisering af rygsöjlen
NO993217L (no) Broenntetningssammensetninger og fremgangsmåter
DK2412368T3 (da) Sammensætning til behandling af ar
DK1089664T3 (da) Elkirurgisk indretning til koagulering og til frembringelse af snit
DE60234660D1 (de) Verankerungselement mit Keil
DE60110002D1 (de) System zur Übertragung von Datenströmen und Zwischenverstärker dafür
DK1351630T3 (da) Implantat til rekonstruktion af led
NO20004830L (no) Gelblanding basert pa overflateaktivt middel for bronnhulls-behandlingsfluider
NO20025488L (no) Stabiliserte tetrasoliumreagenssammensetninger og fremgangsmater for deres anvendelse
DK1334182T3 (da) Fremgangsmåde til fremstilling af ikke-bovint chymosin og anvendelse heraf
NO20025890L (no) Sammensetning for kontroll av brönn-fluid og gassinngrep og fremgangsmåte for bruk av samme
DK1123093T3 (da) Ubiquinonholdig sammensætning egnet til at fremme øget intramitochondrisk transport af ubiquinoner og fremgangsmåder til at anvende det
DK1594867T3 (da) Phenylacetamider og deres anvendelse som glucokinasemodulatorer
DE10295851T1 (de) Dachfensterbaueinheit und Einzelteile
DE60215898D1 (de) Druckempfindliche Silikonklebezusammensetzung und druckempfindliches Klebeband
DK1337599T3 (da) Stabile flydende suspensionssammensætninger og fremgangsmåde til fremstilling af disse.
DK1143977T3 (da) 2-oxy-benzoxazinonderivater til behandling af obesitas
DK0792323T3 (da) Funktionaliserede polyorganosiloxaner og en af fremgangsmåderne til deres fremstilling
NO20035738D0 (no) Kontrollert frigivelsessammensetning og metode for å produsere det samme
DK1278540T3 (da) Anvendelse af IL-18-inhibitorer til behandling og/eller forebyggelsen af aterosklerose
DE60125961D1 (de) Modulierung der allergischer antwort
DK1206436T3 (da) Retinoider til behandling af emfysem